Letter Sequence Other |
---|
|
|
MONTHYEARML21245A0552021-09-0202 September 2021 Shine Medical Technologies, LLC Schedule Update Project stage: Request ML21320A0662021-11-16016 November 2021 Shine Technologies, LLC Operating License Application Supplement No. 12 Submittal of a Revision to the Shine Supplement to the Environmental Report Project stage: Supplement ML22027A3542022-01-27027 January 2022 Shine Technologies, LLC, Submittal of Application for an Operating License Supplement No. 15 Submittal of the Phased Startup Operations Application Supplement Project stage: Supplement ML22027A3532022-01-27027 January 2022 Shine Technologies, LLC, Submittal of Application for an Operating License Supplement No. 15 Submittal of the Phased Startup Operations Application Supplement Project stage: Request ML22047A1792022-02-17017 February 2022 Shine Review Schedule Update Letter-Phased Approach Project stage: Other ML22063A7042022-05-0606 May 2022 Shine Medical Technologies, LLC - Request for Additional Information Related to the Phased Approach Project stage: RAI ML22094A1142022-05-23023 May 2022 Shine Medical Technologies LLC - Draft Regulatory Audit Plan for Phased Approach Session 2 Project stage: Draft Other ML22061A2122022-08-24024 August 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for Phased Approach - Session 1 Project stage: Other ML22105A1102022-08-26026 August 2022 Shine Medical Technologies LLC - Request for Additional Information Related to the OGC Review of Phrase Approach Project stage: RAI ML22263A0272022-09-19019 September 2022 Shine Technologies, LLC - Application for an Operating License - Response to Request for Confirmatory Information Project stage: Request ML22258A3132022-09-27027 September 2022 Meeting Summary to Discuss Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML22287A1852023-02-0101 February 2023 Shine Technologies, LLC Regulatory Report on the Audit of Phased Startup Operations Application Supplement Project stage: Other 2022-05-06
[Table View] |
|
---|
Category:Letter
MONTHYEARML23229A0202023-08-17017 August 2023 Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML23087A2272023-05-0505 May 2023 Shine Technologies, LLC - Issuance of Amendment No. 4 to Construction Permit No. CPMIF-001 for the Receipt and Possession of Contained Special Nuclear Material ML23086C0502023-04-27027 April 2023 Shine Technologies, LLC - Letter, Environmental Assessment and Finding of No Significant Impact ML23088A3382023-04-0505 April 2023 Shine Technologies, LLC - Review of the Physical Security Plan in Support of an Operating License for a Medical Radioisotope Production Facility ML23010A1982023-02-24024 February 2023 Shine Technologies, LLC - Letter: Safety Evaluation Report for the Shine Medical Radioisotope Production Facility Operating License Application ML23048A2442023-02-17017 February 2023 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML23034A1872023-02-0303 February 2023 Shine Medical Technologies, LLC Notice of Availability of Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility (Docket Number: 50-608) ML23010A2382023-02-0303 February 2023 Shine Technologies, LLC - Individual Notice of Consideration FRN Letter ML23023A0942023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0922023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0862023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23024A1682023-02-0101 February 2023 Letter to Ken Westlake, EPA Region 5 - Issuance of Final EIS Supplement Related to the Operating License ML23024A1742023-02-0101 February 2023 Dr. Gregory Piefer, Chief Executive Officer - Issuance of Final EIS Supplement Related to the Operating License ML22287A1852023-02-0101 February 2023 Shine Technologies, LLC Regulatory Report on the Audit of Phased Startup Operations Application Supplement ML22308A2332023-01-0909 January 2023 Shine Technologies LLC - Regulatory Audit Report for Chapter 8 - Irradiation Facility and Radioisotope Production Facility Electrical Power Systems ML22347A2142023-01-0404 January 2023 Shine Technologies LLC - Regulatory Audit Report for I&C Combined Sessions ML22356A1932022-12-22022 December 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Confirmatory Information ML22347A1772022-12-14014 December 2022 Shine Technologies LLC - Regulatory Audit Report for Programmable Logic Lifecycle ML22301A1492022-12-0707 December 2022 Shine Technologies, LLC - Regulatory Audit Report for Chapter 13 - Accident Analysis and Criticality Safety ML22322A2122022-12-0202 December 2022 Shine Medical Technologies - Cybersecurity Audit Summary Report ML22322A2232022-12-0202 December 2022 Shine Medical Technologies - Fire Protection Audit Summary Report ML22348A0672022-12-0101 December 2022 Shine Technologies, LLC - Request for Confirmatory Information Related to Instrumentation and Control Systems ML22335A5722022-12-0101 December 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22292A3192022-11-30030 November 2022 Shine Medical Technologies, LLC Issuance of Order and Amendment No. 3 to Construction Permit No. CPMIF-001 ML22318A1782022-11-14014 November 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22304A1262022-10-31031 October 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22279A9512022-10-0606 October 2022 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 ML22271A9632022-09-28028 September 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 31 Revision to the Phased Startup Operations Application Supplement ML22263A3442022-09-20020 September 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information ML22263A0272022-09-19019 September 2022 Shine Technologies, LLC - Application for an Operating License - Response to Request for Confirmatory Information ML22220A2612022-09-12012 September 2022 Shine Technologies LLC - Regulatory Report on the Audit Chapter 14, Technical Specifications ML22251A3272022-09-0808 September 2022 Shine Technologies, LLC Application for an Operating License Revision 1 of Shine Response to Requests for Additional Information 7-38, 7-40, and 7-48 ML22249A1252022-08-31031 August 2022 Shine Technologies, LLC Final Safety Analysis Report - Application for an Operating License Supplement No. 30, Cover Letter ML22105A1102022-08-26026 August 2022 Shine Medical Technologies LLC - Request for Additional Information Related to the OGC Review of Phrase Approach ML22061A2122022-08-24024 August 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for Phased Approach - Session 1 ML22213A0492022-08-0101 August 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22187A1342022-08-0101 August 2022 Shine Technologies, LLC - Update to Operating License Application Technical Review Schedule ML22206A2082022-07-27027 July 2022 Shine Medical Technologies, LLC - Request for Confirmatory Information Related to Radiation Protection Program and Waste Management ML22207A0062022-07-26026 July 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 29 ML22202A4492022-07-21021 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 28 - Submittal of a Revision to the Shine Emergency Plan ML22188A2412022-07-14014 July 2022 Meeting with Shine Medical Technologies, LLC (EPID No. L-2019-NEW-0004), to Discuss Development of Shine'S Cybersecurity Program for It'S Medical Isotope Production Facility ML22175A0392022-07-11011 July 2022 Letter to Reid Nelson, Achp Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0542022-07-0808 July 2022 Letter to Gregory Piefer - Notice of Availability of the Draft EIS Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML22175A0912022-07-0808 July 2022 Notice of Availability and Request for Comments on the Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine (Multiple Tribal Letters) ML22175A0772022-07-0808 July 2022 Letter to Daina Penkiunas - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0632022-07-0808 July 2022 Letter to Ken Westlake, EPA Region 5 - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22188A1942022-07-0707 July 2022 Shine Technologies, LLC, Application for an Operating License Supplement No. 27 ML22188A0562022-07-0707 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 26 Submittal of a Revision to the Shine Material Control and Accounting Plan ML22223A0662022-07-0606 July 2022 Shine Technologies, LLC, Application for an Operating License, Revision 1 of the Response to Requests for Additional Information Related to Cyber Security ML22175A0742022-07-0101 July 2022 Letter to Mary Buelow Maintenance of Reference Materials at the Hedberg Public Library for the Environmental Review of Shine Medical Technologies, LLC Operating License Application 2023-08-17
[Table view] |
Text
February 17, 2022 Dr. Gregory Piefer Chief Executive Officer SHINE Technologies, LLC 3400 Innovation Court Janesville, WI 53546
SUBJECT:
SHINE MEDICAL TECHNOLOGIES, LLC - UPDATE TO OPERATING LICENSE APPLICATION TECHNICAL REVIEW SCHEDULE IN RESPONSE TO PHASED STARTUP OPERATIONS APPLICATION SUPPLEMENT (EPID NO. L-2022-NEW-0004)
Dear Dr. Piefer:
The purpose of this letter is to provide an update on schedule and resource needs in response to the SHINE Medical Technologies, LLC (SHINE) Application for an Operating License Supplement No.15, Submittal of the Phased Startup Operations Application Supplement, dated January 27, 2022 (Agencywide Documents Access and Management System (ADAMS)
Accession No. ML22027A354). In anticipation of this supplement, the U.S. Nuclear Regulatory Commission (NRC) sent SHINE a letter on August 3, 2021, acknowledging that a new review schedule would be developed once the NRC staff received and assessed the supplement (ADAMS Accession No. ML21209A997). As such, based on the review of the phased startup operations application supplement, the NRC staff determined that it could accommodate the additional scope and plans to complete the operating license application review by October 2022, in accordance with the generic milestone schedule for non-power production or utilization facility operating licensing application reviews, as part of the NRCs implementation of Section 102(c) of the Nuclear Energy Innovation and Modernization Act. To itemize the resources required to support the review of the phased startup operations application supplement, the NRC staff created a new enterprise project identifier (EPID No. L-2022-NEW-0004). The NRC staff anticipates that the total level of effort needed to support this review will be up to 1,000 staff hours (approximately 5 percent of the original estimate of 22,000 staff hours for the review of the SHINE operating license application).
Enclosed with this letter is the current SHINE Operating License Application Technical Review Schedule. The NRC staff will follow the enclosed schedule to complete the reviews required by Title 10 of the Code of Federal Regulations (10 CFR) Part 50, Domestic Licensing of Production and Utilization Facilities, and 10 CFR Part 51, Environmental Protection Regulations for Domestic Licensing and Related Regulatory Functions. This review schedule does not account for potential delays associated with the completion of construction of the facility.
In the coming months, the NRC staff expects to conduct additional regulatory audits and public meetings with SHINE to further the NRC staffs understanding of the information provided and promote the efficiency of the NRC staffs review. The NRC staff may need to issue requests for additional information as part of its review to resolve information insufficiencies in the
supplement and to support the NRC staffs findings of reasonable assurance. Untimely resolution of information insufficiencies, particularly in the phased startup operations application supplement and remainder of the instrumentation and control systems review, may result in extending the review schedule. Such circumstances include applicant delays in providing requested information to the NRC staff and the receipt of new information affecting the scope of the review. The NRC staff will promptly communicate any schedule changes that would extend the expected review completion date beyond October 2022.
If you have any questions, please contact me at (301) 415-1053, or by electronic mail at Holly.Cruz@nrc.gov.
Sincerely, Signed by Cruz, Holly on 02/17/22 Holly D. Cruz, Senior Project Manager Non-Power Production and Utilization Facility Licensing Branch Division of Advanced Reactors and Non-Power Production and Utilization Facilities Office of Nuclear Reactor Regulation Docket No. 50-608 Construction Permit No. CPMIF-001
Enclosure:
As stated cc w/enclosure: See next page
SHINE Medical Technologies, LLC Docket No. 50-608 cc:
Jeff Bartelme Mark Freitag Licensing Manager City Manager SHINE Technologies, LLC P.O. Box 5005 3400 Innovation Court Janesville, WI 53547-5005 Janesville, WI 53546 Bill McCoy Nathan Schleifer 1326 Putnam Avenue General Counsel Janesville, WI 53546 SHINE Technologies, LLC 3400 Innovation Court Alfred Lembrich Janesville, WI 53546 541 Miller Avenue Janesville, WI 53548 Christopher Landers Director, Office of Conversion National Nuclear Security Administration, NA 23 U.S. Department of Energy 1000 Independence Ave SW Washington, DC 20585 Mark Paulson, Supervisor Radiation Protection Section Wisconsin Department of Health Services P.O. Box 2659 Madison, WI 53701-2659 Shelley Warwick Environmental Analysis Specialist-South Team Wisconsin Department of Natural Resources 3911 Fish Hatchery Road Fitchburg, WI 53711 Test, Research and Training Reactor Newsletter Attention: Amber Johnson Dept of Materials Science and Engineering University of Maryland 4418 Stadium Drive College Park, MD 20742-2115
ML22047A179 NRR-106 OFFICE NRR/DANU/PM NRR/DANU/LA NRR/DANU/BC NRR/DANU/PM NAME HCruz NParker JBorromeo HCruz DATE 2/14/2022 2/17/2022 2/17/2022 2/17/2022 SHINE Medical Technologies, LLC Operating License Application Technical Review Schedule Previous Updated Actual Technical Scheduled Scheduled Milestone Completion Status Review Area Completion Completion Date Date Date Receipt of Operating Safety and August 2019 - August 2019 Complete License Application Environmental Acceptance and Docketing Safety and of Operating License October 2019 - October 2019 Complete Environmental Application Environmental Scoping December December Environmental - Complete Meeting 2019 2019 Issuance of Notice of Safety and Opportunity to Request January 2020 - January 2020 Complete Environmental Hearing Closing of Opportunity to Safety and March 2020 - March 2020 Complete Request Hearing Environmental Advisory Committee on Reactor Safeguards (ACRS) September November Safety - Complete Subcommittee Information 2020 2020 Meeting SHINE Submission of Source and Byproduct Safety and April 2021 - April 2021 Complete Materials License Environmental Amendment Request Issuance of Source and Safety and November December Byproduct Materials License TBD Complete Environmental 2021 2021 Amendment Request SHINE Submission of November November Environmental Report Environmental TBD Complete 2021 2021 Supplement SHINE Submission of Operating License Safety and July 2021 January 2022 January 2022 Complete Application Supplement for Environmental Staggered Approach ACRS Project Overview Safety N/A February 2022 February 2022 Complete Meeting Enclosure
Previous Updated Actual Technical Scheduled Scheduled Milestone Completion Status Review Area Completion Completion Date Date Date NUREG Publication of Draft Supplemental Environmental Environmental August 2021 April 2022 TBD Pending Impact Statement March -
ACRS Subcommittee Safety TBD September TBD Pending Meetings 2022 Draft Safety Evaluation September September Safety TBD Pending Report Complete 2021 2022 ACRS Full Committee September Safety TBD TBD Pending Meeting 2022 Final Safety Evaluation Safety October 2021 October 2022 TBD Pending Report NUREG Publication of Final December Supplemental Environmental Environmental October 2022 TBD Pending 2021 Impact Statement